Evidence map›Paper›PMID 10848598›Full record

ArticleMolecular and cellular biology2000

The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors.

Q Pang, S Fagerlie, T A Christianson, W Keeble, G Faulkner, J Diaz, R K Rathbun, G C Bagby

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 126 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. TNF-α signaling in Fanconi anemia.Blood cells, molecules & diseases · 2014
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Mouse models of Fanconi anemia.Mutation research · 2009
    Review
  19. Fanconi anemia.Hematology/oncology clinics of North America · 2009
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Q PangOregon Cancer Center, Department of Medicine, Oregon Health Sciences University, Portland, OR 97201, USA.
S Fagerlie
T A Christianson
W Keeble
G Faulkner
J Diaz
R K Rathbun
G C Bagby
Portland VA Medical Center · USOregon Health & Science University · US

Funding

Xenograft CoreP01HL048546 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI FLEMING, WILLIAM H · 1994 to 2020
$36.4M
NHLBI NIH HHS HL48546NHLBI NIH HHS P01 HL048546
6 · The paper itself

Abstract

Hematopoietic progenitor cells from Fanconi anemia (FA) group C (FA-C) patients display hypersensitivity to the apoptotic effects of gamma interferon (IFN-gamma) and constitutively express a variety of IFN-dependent genes. Paradoxically, however, STAT1 activation is suppressed in IFN-stimulated FA cells, an abnormality corrected by transduction of normal FANCC cDNA. We therefore sought to define the specific role of FANCC protein in signal transduction through receptors that activate STAT1. Expression and phosphorylation of IFN-gamma receptor alpha chain (IFN-gammaRalpha) and JAK1 and JAK2 tyrosine kinases were equivalent in both normal and FA-C cells. However, in coimmunoprecipitation experiments STAT1 did not dock at the IFN-gammaR of FA-C cells, an abnormality corrected by transduction of the FANCC gene. In addition, glutathione S-transferase fusion genes encoding normal FANCC but not a mutant FANCC bearing an inactivating point mutation (L554P) bound to STAT1 in lysates of IFN-gamma-stimulated B cells and IFN-, granulocyte-macrophage colony-stimulating factor- and stem cell factor-stimulated MO7e cells. Kinetic studies revealed that the initial binding of FANCC was to nonphosphorylated STAT1 but that subsequently the complex moved to the receptor docking site, at which point STAT1 became phosphorylated. The STAT1 phosphorylation defect in FA-C cells was functionally significant in that IFN induction of IFN response factor 1 was suppressed and STAT1-DNA complexes were not detected in nuclear extracts of FA-C cells. We also determined that the IFN-gamma hypersensitivity of FA-C hematopoietic progenitor cells does not derive from STAT1 activation defects because granulocyte-macrophage CFU and erythroid burst-forming units from STAT1(-/-) mice were resistant to IFN-gamma. However, BFU-E responses to SCF and erythropoietin were suppressed in STAT(-/-) mice. Consequently, because the FANCC protein is involved in the activation of STAT1 through receptors for at least three hematopoietic growth and survival factor molecules, we reason that FA-C hematopoietic cells are excessively apoptotic because of an imbalance between survival cues (owing to a failure of STAT1 activation in FA-C cells) and apoptotic and mitogenic inhibitory cues (constitutively activated in FA-C cells in a STAT1-independent fashion).

Indexed as

Cell Cycle ProteinsNuclear ProteinsProto-Oncogene ProteinsAnimalsB-LymphocytesCell LineDNA-Binding ProteinsFanconi AnemiaFanconi Anemia Complementation Group C ProteinFanconi Anemia Complementation Group ProteinsGrowth SubstancesHumansInterferon-gammaInterferon gamma ReceptorInterferon Regulatory Factor-1Janus Kinase 1Cell Cycle ProteinsDNA-Binding ProteinsFANCC protein, humanFancc protein, mouseFanconi Anemia Complementation Group C ProteinFanconi Anemia Complementation Group ProteinsGrowth SubstancesInterferon-gammaInterferon gamma ReceptorInterferon Regulatory Factor-1IRF1 protein, humanIrf1 protein, mouseJAK1 protein, humanJak1 protein, mouseJAK2 protein, humanJak2 protein, mouseJanus Kinase 1Janus Kinase 2Nuclear ProteinsPhosphoproteinsProteinsProtein-Tyrosine KinasesProto-Oncogene ProteinsReceptors, InterferonSTAT1 protein, humanStat1 protein, mouseSTAT1 Transcription FactorTrans-Activators

Identifiers

PMID10848598
PMCPMC85895
OpenAlexW1975368252

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.